Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood safety

M E Chamberland1, J Epstein, R Y Dodd

  • 1Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Emerging Infectious Diseases
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of a Client-Level Dataset: 20 Years of National Child Traumatic Stress Network Data Collection.

International journal of methods in psychiatric research·2026
Same author

Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis.

Seminars in arthritis and rheumatism·2024
Same author

An algorithm to determine the date when the McDonald criteria are met for the diagnosis of relapsing-remitting multiple sclerosis.

Revue neurologique·2022
Same author

Development and validation of the Flare-OA questionnaire for measuring flare in knee and hip osteoarthritis.

Osteoarthritis and cartilage·2022
Same author

Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients.

Revue neurologique·2021
Same author

Cystic papillary adenoma of the seminal vesicle.

BMC urology·2021
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Reducing transfusion-transmitted infections requires ongoing vigilance. Strategies include assessing new agents, improving screening and inactivation, and enhancing surveillance, especially in developing nations.

Area of Science:

  • Transfusion Medicine
  • Infectious Disease Epidemiology
  • Public Health

Background:

  • Blood products, being biologic, carry inherent risks of transfusion-transmitted infections (TTIs).
  • Emerging infectious agents pose a continuous threat to blood safety.
  • Zero risk for TTIs is currently unattainable.

Purpose of the Study:

  • To outline a comprehensive approach for managing emerging transfusion-transmitted infections.
  • To emphasize the need for continuous vigilance in blood product safety.
  • To highlight disparities in TTI prevention and surveillance globally.

Main Methods:

  • Assessing the transmissibility of emerging infectious agents via transfusion.
  • Developing and implementing effective prevention strategies (screening, donor deferral).

Related Experiment Videos

  • Enhancing viral and bacterial inactivation methods for blood products.
  • Establishing surveillance systems for known and novel TTIs.

    • Main Results:

    • A multi-faceted approach is necessary to mitigate TTI risks.
    • Balancing blood product safety with availability requires careful consideration.
    • Significant gaps exist in TTI prevention and surveillance in the developing world.

    Conclusions:

    • Continuous vigilance and proactive strategies are crucial for blood product safety.
    • Global collaboration is essential to address TTIs, particularly in resource-limited settings.
    • Improving screening, inactivation, and surveillance is key to minimizing transfusion-transmitted infections.